Clarithromycin versus doxycycline in the treatment of rosacea.
Torresani
C
C
Department of Dermatology, Parma University, Italy.
Pavesi
A
A
Manara
G C
GC
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D017291:Clarithromycin / Q000008:administration & dosage / Q000627:therapeutic use*; D004318:Doxycycline / Q000008:administration & dosage / Q000627:therapeutic use*; D004361:Drug Tolerance; D004890:Erythema / Q000503:physiopathology; D005260:Female; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D012393:Rosacea / Q000188:drug therapy* / Q000453:epidemiology; D012871:Skin Diseases / Q000503:physiopathology; D013684:Telangiectasis / Q000503:physiopathology; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D017291:Clarithromycin; D004318:Doxycycline